Supernus Pharmaceuticals | SUPN - Stock


Supernus Pharmaceuticals reported $107.03M in Stock for its fiscal quarter ending in June of 2026.





Stock Change Date
Abbott USD 6.99B 501M Mar/2026
ANI Pharmaceuticals USD 143.15M 319K Jun/2026
Aurora Cannabis CAD 175.08M 55.48M Mar/2026
Bristol-Myers Squibb USD 2.74B 19M Jun/2026
Canopy Growth CAD 110.51M 4.96M Mar/2026
Cara Therapeutics USD 900K 0 Mar/2025
Corcept Therapeutics USD 13.18M 295K Jun/2026
Eisai JPY 257.55B 21.09B Mar/2026
Eli Lilly USD 16.79B 2.26B Jun/2026
Novo Nordisk DKK 45.65B 21.26B Jun/2025
Pacira USD 134.57M 15.8M Jun/2026
Perrigo USD 1.06B 56.9M Jun/2026
Pfizer USD 9.94B 722M Jun/2026
Supernus Pharmaceuticals USD 107.03M 3.74M Jun/2026
United Therapeutics USD 193.8M 15.5M Jun/2026
Xeris Pharmaceuticals USD 80.93M 6.7M Jun/2026